Literature DB >> 4110315

Prevention of thrombosis after pelvic surgery by British dextran 70.

J Bonnar, J Walsh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4110315     DOI: 10.1016/s0140-6736(72)90410-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  26 in total

1.  Low-dose heparin prophylaxis against fatal pulmonary embolism.

Authors:  S Sagar; J Massey; J M Sanderson
Journal:  Br Med J       Date:  1975-11-01

2.  The effect of dextran on the lysability of ex vivo thrombi.

Authors:  M Aberg; S E Bergentz; U Hedner
Journal:  Ann Surg       Date:  1975-03       Impact factor: 12.969

3.  Letter: Diagnostic criteria in the 125i-fibrinogen test.

Authors:  P Atkins; I K Brown; G J Santer; P M Robb
Journal:  Br Med J       Date:  1975-10-18

4.  Prophylaxis of venous thromboembolism.

Authors:  V V Kakkar
Journal:  Proc R Soc Med       Date:  1975-04

5.  [Perioperative prevention of thromboembolism in gynecology].

Authors:  W E Schreiner
Journal:  Arch Gynecol       Date:  1986

Review 6.  Methods for Generating Hydrogel Particles for Protein Delivery.

Authors:  Allen L Liu; Andrés J García
Journal:  Ann Biomed Eng       Date:  2016-05-09       Impact factor: 3.934

7.  Preoperative prediction of postoperative deep vein thrombosis.

Authors:  J K Clayton; J A Anderson; G P McNicol
Journal:  Br Med J       Date:  1976-10-16

8.  Hazards in the management of large intra-abdominal tumours.

Authors:  R W Hoile
Journal:  Ann R Coll Surg Engl       Date:  1976-09       Impact factor: 1.891

9.  Prevention of postoperative thromboembolism by various treatments. Controlled clinical trial in 632 patients using 125I-fibrinogen uptake test and lung perfusion scans in patients with deep venous thrombosis.

Authors:  G Hör; G Buttermann; W Theisinger; H W Pabst
Journal:  Eur J Nucl Med       Date:  1976-12-30

Review 10.  Antithrombotic drugs: part II.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.